NRx Pharmaceuticals Inc.

NRXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.23

-$0.06 (-1.82%)

Sep 22, 2026, 12:06 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	7.8M	1.44M	4.6M	20.05M	27.61M	1.86M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	397K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	316K	349K	431K	21K	15K	11K
Receivables	161K	n/a	6K	7K	n/a	831K
Inventory	n/a	n/a	n/a	n/a	n/a	214K
Other Current Assets	n/a	n/a	n/a	n/a	n/a	26K
Total Current Assets	8.89M	3.3M	6.88M	25.8M	32.71M	2.93M
Property-Plant & Equipment	633K	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	2.72M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.06M	349K	431K	21K	15K	11K
Total Assets	12.96M	3.65M	7.32M	25.82M	32.73M	2.94M
Account Payables	4.27M	4.13M	4.63M	2.08M	3.69M	3.15M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	1.57M	9.16M	7.7M	518K	249K
Other Current Liabilities	18.31M	10.93M	4.42M	37K	4.87M	n/a
Total Current Liabilities	28.58M	21.86M	19.05M	15.59M	11.92M	46.16M
Long-Term Debt	n/a	5.01M	n/a	2.82M	n/a	548K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	315K	5.01M	n/a	2.82M	n/a	548K
Total Liabilities	28.89M	26.87M	19.05M	18.41M	11.92M	46.71M
Total Debt	631K	6.58M	9.16M	10.53M	518K	797K
Book Value	-15.94M	-23.22M	-11.73M	7.41M	20.81M	-43.77M
Book Value Per Share	-0.74	-2.21	-1.55	0.11	0.44	-80.08
Common Stock	32K	15K	84K	67K	59K	43K
Retained Earnings	-306.9M	-278.27M	-253.15M	-223M	-183.24M	-90.18M
Comprehensive Income	n/a	n/a	-3K	n/a	n/a	n/a
Shareholders Equity	-15.94M	-23.22M	-11.73M	7.41M	20.81M	-43.77M
Total Investments	397K	n/a	n/a	n/a	n/a	n/a